Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes

L Musey, Y Ding, J Cao, J Lee, C Galloway… - Journal of …, 2003 - Am Soc Microbiol
L Musey, Y Ding, J Cao, J Lee, C Galloway, A Yuen, KR Jerome, MJ McElrath
Journal of virology, 2003Am Soc Microbiol
Induction of adaptive immunity to human immunodeficiency virus type 1 (HIV-1) at the
mucosal site of transmission is poorly understood but crucial in devising strategies to control
and prevent infection. To gain further understanding of HIV-1-specific T-cell mucosal
immunity, we established HIV-1-specific CD8+ cytotoxic T-lymphocyte (CTL) cell lines and
clones from the blood, cervix, rectum, and semen of 12 HIV-1-infected individuals and
compared their specificities, cytolytic function, and T-cell receptor (TCR) clonotypes. Blood …
Abstract
Induction of adaptive immunity to human immunodeficiency virus type 1 (HIV-1) at the mucosal site of transmission is poorly understood but crucial in devising strategies to control and prevent infection. To gain further understanding of HIV-1-specific T-cell mucosal immunity, we established HIV-1-specific CD8+ cytotoxic T-lymphocyte (CTL) cell lines and clones from the blood, cervix, rectum, and semen of 12 HIV-1-infected individuals and compared their specificities, cytolytic function, and T-cell receptor (TCR) clonotypes. Blood and mucosal CD8+ CTL had common HIV-1 epitope specificities and major histocompatibility complex restriction patterns. Moreover, both systemic and mucosal CTL lysed targets with similar efficiency, primarily through the perforin-dependent pathway in in vitro studies. Sequence analysis of the TCRβ VDJ region revealed in some cases identical HIV-1-specific CTL clones in different compartments in the same HIV-1-infected individual. These results clearly establish that a subset of blood and mucosal HIV-1-specific CTL can have a common origin and can traffic between anatomically distinct compartments. Thus, these effectors can provide immune surveillance at the mucosa, where rapid responses are needed to contain HIV-1 infection.
American Society for Microbiology